v3.26.1
Business Combinations
 3 Months Ended
Mar. 31, 2026
Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]  
Business Combinations Business Combinations
Lehan Drugs, Inc.

On July 1, 2025, the Company completed the acquisition of 100% of the outstanding equity interests of Lehan Drugs, Inc. (“Lehan”), an Illinois-based provider of home medical equipment. The acquisition met the definition of a business and was accounted for under the acquisition method of accounting in accordance with ASC 805. The fair value of the consideration totaled approximately $29.2 million.

The following table summarizes the estimated fair values of the consideration paid or payable, assets acquired, and liabilities assumed at the acquisition date (in thousands):
Purchase Price
Cash paid
$27,451 
Contingent consideration
1,750 
TOTAL CONSIDERATION
29,201 
Identifiable Assets
Cash and cash equivalents383 
Accounts receivable1,833 
Inventory786 
Prepaid expenses and other assets176 
Property and equipment, net959 
Lease assets60 
Identifiable intangibles628 
TOTAL ASSETS4,825 
Identifiable Liabilities
Trade payables490 
Deferred revenue467 
Accrued liabilities557 
Current portion of lease liabilities41 
Long-term lease liabilities18 
TOTAL LIABILITIES1,573 
Net assets acquired
3,252 
Resulting goodwill$25,949 
Goodwill recognized in this transaction primarily represents the expected realization of operational synergies, the integration of Lehan’s maternal health services within Viemed’s broader clinical platform, and the strategic expansion of the Company’s geographic presence across the Midwest. All of the goodwill is deductible for income tax purposes. The results of Lehan’s operations have been included in the Company’s consolidated financial statements since the date of acquisition.